The company, which is a brand of Neurotherapeutics Ltd, focuses on providing a safe and effective non-drug treatment for tic disorder that can be used outside of the clinic and gives individuals control over their tics. This is achieved through the use of peripheral nerve stimulation, which increases the power and synchronicity of brain oscillations associated with the suppression of movements. Neupulse has demonstrated that this type of stimulation can dramatically reduce the frequency of tics and remove the urge-to-tic in individuals with tic disorders, without affecting intentional movements or cognitive functions such as attention. The company's research priorities were shaped by feedback from individuals with tic disorders and their families, who highlighted the need for such a treatment.